Telix Pharmaceuticals revenue was $492.58M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TLX annual revenue was $486.5M, with 42.3% growth year-over-year.
TLX past revenue growth
How has TLX's revenue growth performed historically?
Telix Pharmaceuticals (NASDAQ: TLX) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Telix Pharmaceuticals's revenue was N/A.
What was Telix Pharmaceuticals's revenue in 2024?
Telix Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $486.46 million, a 42.3% increase year over year.
How much does Telix Pharmaceuticals make in a day?
Based on Telix Pharmaceuticals annual revenue for the past two years, TLX makes an average of $1,134,702.30 per day.
What was Telix Pharmaceuticals's annual revenue growth in the past year?
As of Q2 2025, Telix Pharmaceuticals's revenue has grown 42.3% year over year. This is 455.4 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Telix Pharmaceuticals's revenue in the past year totaled $492.58 million.
How much does Telix Pharmaceuticals make in a year?
Telix Pharmaceuticals's revenue by year for the past two years is:
Telix Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $486.46 million, a 42.3% increase year over year.
Telix Pharmaceuticals's annual revenue for Dec 31, 2023 was $341.87 million, a 218.17% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.